ALLARISA
LIVE

Serial Number

50142045

Owner

Axsome Therapeutics, Inc.

Attorney

Brent A. Johnson

Filing Date

Oct 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ALLARISA Trademark

Serial Number: 50142045

ALLARISA is a trademark filed by Axsome Therapeutics, Inc. on October 2, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Axsome Therapeutics, Inc. (84 trademarks)

New York, NY 10007

Entity Type: 03

Trademark Details

Filing Date

October 2, 2026

Registration Date

Not Registered

Goods & Services

Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, cataplexy in narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss

Filing History

APPLICATION FILING RECEIPT MAILED
Oct 2, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2026 NWOS
NEW APPLICATION ENTERED
Oct 2, 2026 NWAP